A novel system for the production of fully deleted adenovirus vectors that does not require helper adenovirus

Gene Therapy

Volumn 8, Issue 11, 2001, Pages 846-854

  Cheshenko, N ^a   Krougliak, N ^a   Eisensmith, R C ^a   Krougliak, V A ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

Baculovirus; Baculovirus adenovirus hybrid; Fully deleted adenovirus vector; Gene therapy; Production

Indexed keywords

BETA GALACTOSIDASE; CRE RECOMBINASE; DNA; PLASMID DNA; VIRUS VECTOR;

ADENOVIRUS; ANIMAL CELL; ARTICLE; BACULOVIRUS; CONTROLLED STUDY; GENE EXPRESSION; GENE INSERTION; GENE STRUCTURE; GENETIC TRANSDUCTION; GENETIC TRANSFECTION; HELPER VIRUS; HUMAN; HUMAN CELL; NONHUMAN; PRIORITY JOURNAL; VIRUS GENOME; VIRUS HYBRID; VIRUS INFECTION; VIRUS RECOMBINANT; VIRUS REPLICATION; VIRUS TITRATION;

ADENOVIRIDAE; BACULOVIRIDAE; BETA-GALACTOSIDASE; BLOTTING, SOUTHERN; CELL LINE; GENE DELETION; GENE EXPRESSION; GENES, VIRAL; GENETIC ENGINEERING; GENETIC VECTORS; HUMANS; TRANSDUCTION, GENETIC;

EID: 0034973111     PISSN: 09697128     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.gt.3301459     Document Type: Article

References (48)

1. The murine cellular immume response to adenovirus type 5
2. MHC class I-restricted cytotoxic T lymphocytes to viral antigens destroy hepatocytes in mice infected with E1-deleted recombinant adenoviruses
3. Cellular immunity to viral antigens limits E1-deleted adenoviruses for gene therapy
4. Long-term humoral and cellular immunity induced by a single immunization with replication-defective adenovirus recombinant vector
5. Inactivation of E2a in recombinant adenoviruses improves the prospect for gene therapy in cystic fibrosis
6. Ablation of E2A in recombinant adenoviruses improves transgene persistence and decreases inflammatory response in mouse liver
7. Characterization of an adenovirus gene transfer vector containing an E4 deletion
8. Development of cell lines capable of complementing E1, E4, and protein IX defective adenovirus type 5 mutants
9. A packaging cell line for propagation of recombinant adenovirus vectors containing two lethal gene-region deletions
10. Lack of persistence of E1-recombinant adenoviral vectors containing a temperature-sensitive E2A mutation in immunocompetent mice and hemophilia B dogs
11. Elimination of both E1 and E2 from adenovirus vectors further improves prospects for in vivo human gene therapy
12. Persistent transgene expression in mouse liver following in vivo gene transfer with a delta E1 / delta E4 adenovirus vector
13. Production and characterization of improved adenovirus vectors with the E1, E2b, and E3 genes deleted
14. Improved production of gutted adenovirus in cells expressing adenovirus preterminal protein and DNA polymerase
15. Rescue, propagation, and partial purification of a helper virus- dependent adenovirus vector
16. Recombination adenovirus deleted of all viral genes for gene therapy of cystic fibrosis
17. A new adenoviral vector: Replacement of all viral coding sequences with 28 kb of DNA independently expressing both full-length dystrophin and beta-galactosidase
18. Recombinant adenoviruses with large deletions generated by Cre- mediated excision exhibit different biological properties compared with first-generation vectors in vitro and in vivo
19. A helper-dependent adenovirus vector system: Removal of helper virus by Cre-mediated excision of the viral packaging signal
20. A helper-dependent system for adenovirus vector production helps define a lower limit for efficient DNA packaging
21. Genomic DNA transfer with a high-capacity adenovirus vector results in improved in vivo gene expression and decreased toxicity published erratum appears in Nat Genet 1998 Mar;18(3): 298)
22. An adenoviral vector deleted for all viral coding sequences results in enhanced safety and extended expression of a leptin transgene
23. Effects of stuffer DNA on transgene expression from helper-dependent adenovirus vectors
24. Administration of helper-dependent adenoviral vectors and sequential delivery of different vector serotype for long-term liver-directed gene transfer in baboons
25. Expanded-capacity adenoviral vectors - The helper-dependent vectors
26. Optimization of the helper-dependent adenovirus system for production and potency in vivo
27. Efficient gene transfer into human hepatocytes by baculovirus vectors
28. Baculovirus-mediated gene transfer into mammalian cells
29. Gene transfer into hepatocytes and human liver tissue by baculovirus vectors
30. Covalently closed circles of human adenovirus DNA are infectious
31. A simple technique for the rescue of early region I mutations into infectious human adenovirus type 5
32. The cyclization of linear DNA in Escherichia coli by site-specific recombination
33. Bacteriophage P1 cloning system for the isolation, amplification, and recovery of DNA fragments as large as 100 kilobase pairs
34. Interaction of Autographa californica nuclear polyhedrosis virus with two nonpermissive cell lines
35. Baculovirus interaction with nontarget organisms: A virus-borne reporter gene is not expressed in two mammalian cell lines
36. Insect virus: Assays for toxic effects and transformation potential in mammalian cells
37. Insect virus: Assays for viral replication and persistence in mammalian cells
38. Effect of baculovirus on selected vertebrate cells
39. An efficient and flexible system for construction of adenovirus vectors with insertions or deletions in early regions 1 and 3
40. Efficient transduction of mammalian cells by a recombinant baculovirus having the vesicular stomatitis virus G glycoprotein
41. Molecular structure and polymorphic map of the human phenylalanine hydroxylase gene
42. The complete DNA sequence of Autographa californica nuclear polyhedrosis virus
43. Concentration of recombinant baculovirus by cation-exchange chromatography
44. Evaluation of promoter strength for hepatic gene expression in vivo following adenovirus-mediated gene transfer
45. Generation of adenovirus by transfection of plasmids
46. Adenoviruses with nonidentical terminal sequences are viable
47. Use of baculovirus expression vectors
48. Methods for construction of adenovirus vectors